FIELD: microbiology, veterinary medicine, biotechnology. SUBSTANCE: invention relates to the developed transformatory strain Bacillus subtilis producing hybrid colicin E2 showing ability to penetrate through cellular membranes of microorganisms being both the matrix strain Escherichia coli and strains Pseudomonas, Salmonella, Haemophilus, Streptococcus and inducing the endonuclease degradation of bacterial DNA. The strain can be used for the development of the veterinary preparation showing antibacterial and antioxidant properties. EFFECT: bacterial strain indicated above, valuable medicinal properties. 3 dwg
Authors
Dates
2002-08-27—Published
2000-10-30—Filed